Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 126

    2.

    Current perspectives on reperfusion therapy for acute ST-segment elevation myocardial infarction: integrating pharmacologic and mechanical reperfusion strategies.

    Waters RE 2nd, Mahaffey KW, Granger CB, Roe MT.

    Am Heart J. 2003 Dec;146(6):958-68.PMID: 14660986 [PubMed - indexed for MEDLINE]Related articles

    3.

    Coronary stenting and platelet glycoprotein IIb/IIIa receptor blockade in acute myocardial infarction.

    Santoro GM, Bolognese L.

    Am Heart J. 2001 Feb;141(2 Suppl):S26-35. Review.PMID: 11174356 [PubMed - indexed for MEDLINE]Related articles

    5.

    New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines.

    Spinler SA, Hilleman DE, Cheng JW, Howard PA, Mauro VF, Lopez LM, Munger MA, Gardner SF, Nappi JM.

    Ann Pharmacother. 2001 May;35(5):589-617. Review.PMID: 11346067 [PubMed - indexed for MEDLINE]Related articles

    9.

    Comparison of reperfusion regimens with or without tirofiban in ST-elevation acute myocardial infarction.

    Martínez-Ríos MA, Rosas M, González H, Peña-Duque MA, Martínez-Sánchez C, Gaspar J, García H, Gaxiola E, Delgado L, Carrillo J, Leyva JL, Lupi E; SASTRE Investigators.

    Am J Cardiol. 2004 Feb 1;93(3):280-7. Erratum in: Am J Cardiol. 2004 Jul 1;94(1):150. PMID: 14759375 [PubMed - indexed for MEDLINE]Related articles

    10.

    Primary stenting and glycoprotein IIb/IIIa inhibitors in acute myocardial infarction.

    Colombo A, Briguori C.

    Am Heart J. 1999 Aug;138(2 Pt 2):S153-7. Review.PMID: 10426875 [PubMed - indexed for MEDLINE]Related articles

    11.

    Platelet glycoprotein IIb/IIIa receptor blockade: lessening the risk of coronary interventions.

    Pitts WR, Lange RA.

    Thromb Haemost. 1999 Sep;82 Suppl 1:136-8. Review.PMID: 10695505 [PubMed - indexed for MEDLINE]Related articles

    12.

    Frequency, correlates, and clinical implications of myocardial perfusion after primary angioplasty and stenting, with and without glycoprotein IIb/IIIa inhibition, in acute myocardial infarction.

    Costantini CO, Stone GW, Mehran R, Aymong E, Grines CL, Cox DA, Stuckey T, Turco M, Gersh BJ, Tcheng JE, Garcia E, Griffin JJ, Guagliumi G, Leon MB, Lansky AJ.

    J Am Coll Cardiol. 2004 Jul 21;44(2):305-12.PMID: 15261923 [PubMed - indexed for MEDLINE]Related articles

    13.

    Reperfusion in acute myocardial infarction: current concepts.

    Katritsis D, Karvouni E, Webb-Peploe MM.

    Prog Cardiovasc Dis. 2003 May-Jun;45(6):481-92. Review.PMID: 12800129 [PubMed - indexed for MEDLINE]Related articles

    14.

    Glycoprotein IIb/IIIa inhibitors in acute ST segment elevation myocardial infarction.

    Holper EM, Giugliano RP, Antman EM.

    Coron Artery Dis. 1999 Dec;10(8):567-73. Review.PMID: 10599535 [PubMed - indexed for MEDLINE]Related articles

    15.

    Glycoprotein IIb/IIIa receptor inhibitor-thrombolytic combination therapy for acute myocardial infarction.

    Maranian AM, Steinhubl SR.

    Curr Cardiol Rep. 2002 Jul;4(4):313-9. Review.PMID: 12052270 [PubMed - indexed for MEDLINE]Related articles

    16.

    Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.

    Dobrzycki S, Mezyński G, Kralisz P, Prokopczuk P, Nowak K, Kochman W, Zuk J, Bachórzewska-Gajewska H, Sawicki Z, Poniatowski B, Korecki J, Musiał WJ.

    Kardiol Pol. 2006 Aug;64(8):793-9; discussion 800-1.PMID: 16981054 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Platelet GP IIb/IIIa receptor blockers for failed thrombolysis in acute myocardial infarction, alone or as adjunct to other rescue therapies; single centre retrospective analysis of 548 consecutive patients with acute myocardial infarction.

    Ronner E, van Domburg RT, van den Brand MJ, de Feyter PJ, Foley DP, van der Giessen WJ, Serruys PW, Simoons ML.

    Eur Heart J. 2002 Oct;23(19):1529-37.PMID: 12242073 [PubMed - indexed for MEDLINE]Related articles

    18.

    Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.

    Lincoff AM, Califf RM, Moliterno DJ, Ellis SG, Ducas J, Kramer JH, Kleiman NS, Cohen EA, Booth JE, Sapp SK, Cabot CF, Topol EJ.

    N Engl J Med. 1999 Jul 29;341(5):319-27.PMID: 10423466 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.

    Montalescot G, Barragan P, Wittenberg O, Ecollan P, Elhadad S, Villain P, Boulenc JM, Morice MC, Maillard L, Pansiéri M, Choussat R, Pinton P; ADMIRAL Investigators. Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long-Term Follow-up.

    N Engl J Med. 2001 Jun 21;344(25):1895-903.PMID: 11419426 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The use of glycoprotein IIb/IIIa inhibitor therapy in acute ST-segment elevation myocardial infarction: current practice and future trends.

    Campbell KR, Ohman EM, Cantor W, Lincoff AM.

    Am J Cardiol. 2000 Apr 27;85(8A):32C-8C. Review.PMID: 10793178 [PubMed - indexed for MEDLINE]Related articles